Skip to main content

Table 3 Prevalence of MSU crystal deposits at baseline in patients fulfilling and not fulfilling the preliminary remission criteria at 12 months

From: Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study

 

Patients fulfilling the criteria with US evidence of MSU deposits

Patients not fulfilling the criteria with US evidence of MSU deposits

P value

MSU crystal deposits

14 (66.7%)

28 (96.5%)

<0.01

Aggregates

10 (47.6%)

25 (86.2%)

<0.01

DC sign

4 (19.0%)

17 (58.6%)

<0.01

Tophi

8 (38.1%)

20 (69.0%)

0.03

  1. DC double contour, MSU monosodium urate, US ultrasound
  2. Patients fulfilling the preliminary remission criteria (n=21), patients not fulfilling the preliminary remission criteria (n=29)